These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1245147)

  • 1. [The effect of L-tryptophan on L-dopa absorption (author's transl)].
    Weitbrecht WU; Weigel K
    Dtsch Med Wochenschr; 1976 Jan; 101(1):20-2. PubMed ID: 1245147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new determination method of L-dopa in blood (author's transl)].
    Weitbrecht WU; Birg W; Metzel E; Mundinger F
    Med Klin; 1974 Mar; 69(12):500-1. PubMed ID: 4831452
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
    Müller T; Kuhn W
    Mov Disord; 2009 Jul; 24(9):1339-43. PubMed ID: 19425084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopa resorption and dopamin estimation in blood of patients with Parkinson's disease (author's transl)].
    Metzel E; Weitbrecht WU
    Arch Psychiatr Nervenkr (1970); 1974; 219(3):231-7. PubMed ID: 4433233
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphologic and functional alterations in absorptive epithelial cells during L-tryptophan induced inhibition of net sodium and fluid absorption in the rat ileum.
    Teichberg S; Wapnir RA; Zdanowicz M; Roberts B; da Costa Ribeiro H; Lifshitz F
    Lab Invest; 1989 Jan; 60(1):88-101. PubMed ID: 2642990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
    J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa.
    Rivera-Calimlim L
    Br J Pharmacol; 1972 Dec; 46(4):708-13. PubMed ID: 4655269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Acta Med Scand; 1974 Dec; 196(6):459-63. PubMed ID: 4456974
    [No Abstract]   [Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats.
    Cashaw JL; Geraghty CA; McLaughlin BR; Davis VE
    J Neurosci Res; 1987; 18(3):497-503. PubMed ID: 3125342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopa in plasma increases during acute exercise and after exercise training.
    Devalon ML; Miller TD; Squires RW; Rogers PJ; Bove AA; Tyce GM
    J Lab Clin Med; 1989 Sep; 114(3):321-7. PubMed ID: 2504856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of L-tryptophan on fasting intestinal motility and intestinal transit time in the human].
    Lübke HJ; Winkelmann RS; Erckenbrecht JF; Wienbeck M
    Z Gastroenterol; 1987 Nov; 25(11):701-8. PubMed ID: 3433851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and metabolism of L-dopa by the human stomach.
    Rivera-Calimlim L; Dujovne CA; Morgan JP; Lasagna L; Bianchine JR
    Eur J Clin Invest; 1971 May; 1(5):313-20. PubMed ID: 5558777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
    Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
    Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). V. Mechanism of intestinal absorption of D- and L-DOPA-14C in rats.
    Shindo H; Komai T; Kawai K
    Chem Pharm Bull (Tokyo); 1973 Sep; 21(9):2031-8. PubMed ID: 4785106
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo increase of passive intestinal absorption by cotransporter activation in rat.
    Pérez M; Barber A; Ponz F
    Rev Esp Fisiol; 1993 Dec; 49(4):259-64. PubMed ID: 8209102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.